1. Home
  2. BBGI vs GNPX Comparison

BBGI vs GNPX Comparison

Compare BBGI & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBGI
  • GNPX
  • Stock Information
  • Founded
  • BBGI 1961
  • GNPX 2009
  • Country
  • BBGI United States
  • GNPX United States
  • Employees
  • BBGI N/A
  • GNPX N/A
  • Industry
  • BBGI Broadcasting
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BBGI Consumer Discretionary
  • GNPX Health Care
  • Exchange
  • BBGI Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • BBGI 10.0M
  • GNPX 10.8M
  • IPO Year
  • BBGI 2000
  • GNPX 2018
  • Fundamental
  • Price
  • BBGI $5.61
  • GNPX $9.04
  • Analyst Decision
  • BBGI
  • GNPX
  • Analyst Count
  • BBGI 0
  • GNPX 0
  • Target Price
  • BBGI N/A
  • GNPX N/A
  • AVG Volume (30 Days)
  • BBGI 29.0K
  • GNPX 1.5M
  • Earning Date
  • BBGI 11-12-2025
  • GNPX 11-12-2025
  • Dividend Yield
  • BBGI N/A
  • GNPX N/A
  • EPS Growth
  • BBGI N/A
  • GNPX N/A
  • EPS
  • BBGI N/A
  • GNPX N/A
  • Revenue
  • BBGI $227,387,784.00
  • GNPX N/A
  • Revenue This Year
  • BBGI $5.02
  • GNPX N/A
  • Revenue Next Year
  • BBGI N/A
  • GNPX N/A
  • P/E Ratio
  • BBGI N/A
  • GNPX N/A
  • Revenue Growth
  • BBGI N/A
  • GNPX N/A
  • 52 Week Low
  • BBGI $3.67
  • GNPX $7.00
  • 52 Week High
  • BBGI $14.95
  • GNPX $149.50
  • Technical
  • Relative Strength Index (RSI)
  • BBGI 48.61
  • GNPX 76.68
  • Support Level
  • BBGI $5.50
  • GNPX $7.71
  • Resistance Level
  • BBGI $7.02
  • GNPX $11.34
  • Average True Range (ATR)
  • BBGI 0.33
  • GNPX 0.85
  • MACD
  • BBGI -0.04
  • GNPX 1.03
  • Stochastic Oscillator
  • BBGI 7.49
  • GNPX 68.56

About BBGI Beasley Broadcast Group Inc.

Beasley Broadcast Group Inc is a multi-platform media company, whose primary business is operating radio stations throughout the United States. The company offers local and national advertisers integrated marketing solutions across audio, digital and event platforms. It owns and operates stations in the following markets: Atlanta, GA, Augusta, GA, Boston, MA, Charlotte, NC, Detroit, MI, Fayetteville, NC, Fort Myers-Naples, FL, Las Vegas, NV, Middlesex, NJ, Monmouth, NJ, Morristown, NJ, Philadelphia, PA, Tampa-Saint Petersburg, FL, and Wilmington, DE. The company operates in two segments Audio and Digital.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: